Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.
Human African Trypanosomiasis (HAT) is caused by two trypanosome sub-species, Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Drugs available for the treatment of HAT have significant issues related to difficult administration regimes and limited efficacy across species and disease...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC3510080?pdf=render |
id |
doaj-89a7928a2afc4ed9b42b742e35074888 |
---|---|
record_format |
Article |
spelling |
doaj-89a7928a2afc4ed9b42b742e350748882020-11-25T00:53:55ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27352012-01-01611e189610.1371/journal.pntd.0001896Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign.Melissa L SykesJonathan B BaellMarcel KaiserEric ChatelainSarah R MoawadDanny GanameJean-Robert IosetVicky M AveryHuman African Trypanosomiasis (HAT) is caused by two trypanosome sub-species, Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Drugs available for the treatment of HAT have significant issues related to difficult administration regimes and limited efficacy across species and disease stages. Hence, there is considerable need to find new alternative and less toxic drugs. An approach to identify starting points for new drug candidates is high throughput screening (HTS) of large compound library collections. We describe the application of an Alamar Blue based, 384-well HTS assay to screen a library of 87,296 compounds against the related trypanosome subspecies, Trypanosoma brucei brucei bloodstream form lister 427. Primary hits identified against T.b. brucei were retested and the IC(50) value compounds were estimated for T.b. brucei and a mammalian cell line HEK293, to determine a selectivity index for each compound. The screening campaign identified 205 compounds with greater than 10 times selectivity against T.b. brucei. Cluster analysis of these compounds, taking into account chemical and structural properties required for drug-like compounds, afforded a panel of eight compounds for further biological analysis. These compounds had IC(50) values ranging from 0.22 µM to 4 µM with associated selectivity indices ranging from 19 to greater than 345. Further testing against T.b. rhodesiense led to the selection of 6 compounds from 5 new chemical classes with activity against the causative species of HAT, which can be considered potential candidates for HAT early drug discovery. Structure activity relationship (SAR) mining revealed components of those hit compound structures that may be important for biological activity. Four of these compounds have undergone further testing to 1) determine whether they are cidal or static in vitro at the minimum inhibitory concentration (MIC), and 2) estimate the time to kill.http://europepmc.org/articles/PMC3510080?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Melissa L Sykes Jonathan B Baell Marcel Kaiser Eric Chatelain Sarah R Moawad Danny Ganame Jean-Robert Ioset Vicky M Avery |
spellingShingle |
Melissa L Sykes Jonathan B Baell Marcel Kaiser Eric Chatelain Sarah R Moawad Danny Ganame Jean-Robert Ioset Vicky M Avery Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. PLoS Neglected Tropical Diseases |
author_facet |
Melissa L Sykes Jonathan B Baell Marcel Kaiser Eric Chatelain Sarah R Moawad Danny Ganame Jean-Robert Ioset Vicky M Avery |
author_sort |
Melissa L Sykes |
title |
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. |
title_short |
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. |
title_full |
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. |
title_fullStr |
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. |
title_full_unstemmed |
Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. |
title_sort |
identification of compounds with anti-proliferative activity against trypanosoma brucei brucei strain 427 by a whole cell viability based hts campaign. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Neglected Tropical Diseases |
issn |
1935-2735 |
publishDate |
2012-01-01 |
description |
Human African Trypanosomiasis (HAT) is caused by two trypanosome sub-species, Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Drugs available for the treatment of HAT have significant issues related to difficult administration regimes and limited efficacy across species and disease stages. Hence, there is considerable need to find new alternative and less toxic drugs. An approach to identify starting points for new drug candidates is high throughput screening (HTS) of large compound library collections. We describe the application of an Alamar Blue based, 384-well HTS assay to screen a library of 87,296 compounds against the related trypanosome subspecies, Trypanosoma brucei brucei bloodstream form lister 427. Primary hits identified against T.b. brucei were retested and the IC(50) value compounds were estimated for T.b. brucei and a mammalian cell line HEK293, to determine a selectivity index for each compound. The screening campaign identified 205 compounds with greater than 10 times selectivity against T.b. brucei. Cluster analysis of these compounds, taking into account chemical and structural properties required for drug-like compounds, afforded a panel of eight compounds for further biological analysis. These compounds had IC(50) values ranging from 0.22 µM to 4 µM with associated selectivity indices ranging from 19 to greater than 345. Further testing against T.b. rhodesiense led to the selection of 6 compounds from 5 new chemical classes with activity against the causative species of HAT, which can be considered potential candidates for HAT early drug discovery. Structure activity relationship (SAR) mining revealed components of those hit compound structures that may be important for biological activity. Four of these compounds have undergone further testing to 1) determine whether they are cidal or static in vitro at the minimum inhibitory concentration (MIC), and 2) estimate the time to kill. |
url |
http://europepmc.org/articles/PMC3510080?pdf=render |
work_keys_str_mv |
AT melissalsykes identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT jonathanbbaell identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT marcelkaiser identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT ericchatelain identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT sarahrmoawad identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT dannyganame identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT jeanrobertioset identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign AT vickymavery identificationofcompoundswithantiproliferativeactivityagainsttrypanosomabruceibruceistrain427byawholecellviabilitybasedhtscampaign |
_version_ |
1725235891051429888 |